Drug Shortage Report for TRISPAN

Last updated on 2022-10-05 History
Report ID 164214
Drug Identification Number 02470632
Brand name TRISPAN
Common or Proper name Triamcinolone Hexacetonide Injectable Suspension
Company Name MEDEXUS PHARMACEUTICALS INC.
Market Status CANCELLED POST MARKET
Active Ingredient(s) TRIAMCINOLONE HEXACETONIDE
Strength(s) 20MG
Dosage form(s) SUSPENSION
Route of administration INTRASYNOVIAL PERIARTICULAR INTRA-ARTICULAR PERIARTICULAR INTRASYNOVIAL INTRA-ARTICULAR
Packaging size 1 ml ampoule - 10 ampoules/pack
ATC code H02AB
ATC description CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN
Reason for shortage Shortage of an active ingredient.
Anticipated start date 2022-08-30
Actual start date
Estimated end date 2022-10-08
Actual end date 2022-10-04
Shortage status Resolved
Updated date 2022-10-05
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 35 NIXON ROAD, UNIT 10
BOLTON, ONTARIO
CANADA L7E 1K1
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v15 2022-10-05 French Compare
v14 2022-10-05 English Compare
v13 2022-10-05 English Compare
v12 2022-10-05 French Compare
v11 2022-10-05 English Compare
v10 2022-10-05 French Compare
v9 2022-10-05 English Compare
v8 2022-10-05 French Compare
v7 2022-10-05 English Compare
v6 2022-10-05 English Compare
v5 2022-08-31 English Compare
v4 2022-08-30 French Compare
v3 2022-08-30 English Compare
v2 2022-07-06 French Compare
v1 2022-07-06 English Compare

Showing 1 to 15 of 15